Skip to content

Antiviral susceptibility testing of influenza viruses in 2014

Antiviral susceptibility testing of influenza viruses in 2014

The information is based on testing of influenza virus isolates obtained from cell culture, and intends to provide a profile on the proportion of strains with reduced antiviral susceptibility. The date refers to specimen reception by the laboratory. Numbers and trends presented here should be interpreted in light of the small specimen numbers in particular categories.

Antiviral susceptibility testing of influenza A subtype H1 viruses in 2014

Month Amantadine tested Amantadine resistant Oseltamivir tested Oseltamivir - Reduced susceptibility
No. % No. %
Jan 84 84 100.0% 84 4 4.8%
Feb 65 65 100.0% 65 1 1.5%
Mar 10 10 100.0% 10 1 10.0%
Apr 10 10 100.0% 10 0 0.0%
May 0 - - 2 0 0.0%
Jun 0 - - 2 0 0.0%
Jul 0 - - 2 0 0.0%
Aug 0 - - 1 0 0.0%
Sep 0 - - 2 0 0.0%
Oct 0 - - 4 0 0.0%
Nov 0 - - 0 - -
Dec 0 - - 1 0 0.0%

 

Antiviral susceptibility testing of influenza A subtype H3 viruses in 2014

Month Amantadine tested Amantadine resistant Oseltamivir tested Oseltamivir - Reduced susceptibility
No. % No. %
Jan 39 39 100.0% 39 0 0.0%
Feb 19 19 100.0% 19 0 0.0%
Mar 5 5 100.0% 5 0 0.0%
Apr 10 10 100.0% 10 0 0.0%
May 0 - - 8 0 0.0%
Jun 2 2 100.0% 13 0 0.0%
Jul 8 8 100.0% 13 0 0.0%
Aug 3 3 100.0% 15 0 0.0%
Sep 0 - - 12 0 0.0%
Oct 0 - - 11 1* 9.1%
Nov 0 - - 15 0 0.0%
Dec 5 5 100.0% 18 0 0.0%
*N2 gene encoding amino acid change: S331R.

 

Antiviral susceptibility testing of influenza B viruses in 2014

Month Oseltamivir tested Oseltamivir - Reduced susceptibility
No. %
Jan 18 0 0.0%
Feb 10 0 0.0%
Mar 5 0 0.0%
Apr 8 0 0.0%
May 10 0 0.0%
Jun 5 0 0.0%
Jul 3 0 0.0%
Aug 3 0 0.0%
Sep 6 0 0.0%
Oct 5 0 0.0%
Nov 5 0 0.0%
Dec 1 0 0.0%